Nottingham, United Kingdom

Alan Gerald Coombes

This inventor holds 1 USPTO granted patent. Top assignee: Danbiosyst UK Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Gerald Coombes. Retrieved from https://idiyas.com/inventor/alan-gerald-coombes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Gerald Coombes: Innovator in Drug Delivery Systems

Introduction

Alan Gerald Coombes is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on polymer microparticles.

Latest Patents

Coombes holds a patent for "Polymer microparticles for drug delivery." This invention represents a breakthrough in the efficient delivery of pharmaceuticals, enhancing the effectiveness of treatments.

Career Highlights

Alan Coombes is currently associated with Danbiosyst UK Limited, where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential impact on healthcare and drug administration.

Collaborations

Coombes has collaborated with esteemed colleagues, including Ming-Kung Yeh and Paul George Jenkins, to advance research in drug delivery technologies.

Conclusion

Alan Gerald Coombes is a prominent figure in the field of drug delivery, with a focus on innovative solutions that improve patient outcomes. His contributions are paving the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…